| pubmed-article:10604081 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10604081 | lifeskim:mentions | umls-concept:C0031392 | lld:lifeskim |
| pubmed-article:10604081 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:10604081 | lifeskim:mentions | umls-concept:C0031572 | lld:lifeskim |
| pubmed-article:10604081 | lifeskim:mentions | umls-concept:C1527374 | lld:lifeskim |
| pubmed-article:10604081 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:10604081 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:10604081 | pubmed:dateCreated | 2000-1-19 | lld:pubmed |
| pubmed-article:10604081 | pubmed:abstractText | To evaluate the effects of maintenance treatment and durability of gains after treatment discontinuation, responders to either phenelzine (PZ) or cognitive-behavioral group therapy (CBGT) from an acute trial comparing these two treatments as well as pill placebo and a psychotherapy control (educational supportive group therapy) were enrolled into maintenance and treatment-free follow-up phases. | lld:pubmed |
| pubmed-article:10604081 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10604081 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10604081 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10604081 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10604081 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10604081 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10604081 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10604081 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10604081 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10604081 | pubmed:issn | 1091-4269 | lld:pubmed |
| pubmed-article:10604081 | pubmed:author | pubmed-author:KleinD FDF | lld:pubmed |
| pubmed-article:10604081 | pubmed:author | pubmed-author:DaviesSS | lld:pubmed |
| pubmed-article:10604081 | pubmed:author | pubmed-author:MarshallR DRD | lld:pubmed |
| pubmed-article:10604081 | pubmed:author | pubmed-author:KAOP CPC | lld:pubmed |
| pubmed-article:10604081 | pubmed:author | pubmed-author:LiebowitzM... | lld:pubmed |
| pubmed-article:10604081 | pubmed:author | pubmed-author:HoltC SCS | lld:pubmed |
| pubmed-article:10604081 | pubmed:author | pubmed-author:BruchM AMA | lld:pubmed |
| pubmed-article:10604081 | pubmed:author | pubmed-author:GoetzDD | lld:pubmed |
| pubmed-article:10604081 | pubmed:author | pubmed-author:SchneierF RFR | lld:pubmed |
| pubmed-article:10604081 | pubmed:author | pubmed-author:HeimbergR GRG | lld:pubmed |
| pubmed-article:10604081 | pubmed:author | pubmed-author:HopeD ADA | lld:pubmed |
| pubmed-article:10604081 | pubmed:author | pubmed-author:JusterH RHR | lld:pubmed |
| pubmed-article:10604081 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10604081 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:10604081 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10604081 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10604081 | pubmed:pagination | 89-98 | lld:pubmed |
| pubmed-article:10604081 | pubmed:dateRevised | 2011-8-25 | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:meshHeading | pubmed-meshheading:10604081... | lld:pubmed |
| pubmed-article:10604081 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10604081 | pubmed:articleTitle | Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. | lld:pubmed |
| pubmed-article:10604081 | pubmed:affiliation | New York State Psychiatric Institute, NY 10032, USA. | lld:pubmed |
| pubmed-article:10604081 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10604081 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10604081 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:10604081 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10604081 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10604081 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10604081 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10604081 | lld:pubmed |
